International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

LETTER FROM THE 2023 PRESIDENT

DEAR COLLEAGUES

Reflecting on the milestones of 2023 and my inaugural year as the IPC President, I am pleased to share our progress and achievements. The collaboration and commitment of our Board Members, Councilors, Fellows, Staff, and Corporate Members have allowed us to make meaningful strides in various aspects of psoriasis research, education, and care.

Anticipating the future with optimism is inherent to our substance. While I make this statement mine, I am aware that we are not living in an ivory tower, impermeable to the multiple tragedies currently happening across the globe. That should motivate us at IPC to reach new objectives of progress in care and science and to open new perspectives ahead in the coming year, especially as we celebrate our 20th anniversary. Rest assured that we will do so in a spirit of transparency, of inclusivity, and of tolerance. As we reflect on the successes of 2023, we refuse to rest on our laurels, and we eagerly look forward to implementing a new strategic plan that will guide our activities in 2024 and years to come. This strategic vision and our commitment to advancing psoriasis care worldwide promise a year of growth, impact, and innovation.

We express our gratitude for your steadfast support, and together, let’s make the IPC’s 20th year a milestone marked by progress and a brighter future for individuals affected by psoriasis worldwide.

Thank you for your continued support.

Hervé Bachelez Headshot

Hervé Bachelez, MD, PhD

PRESIDENT

Christy Langan Headshot

Christy Langan              

CEO